Pakistan’s Pharma Sector Delivers Record-Breaking $457 Million in Exports for FY25

The exports by Pakistani pharmaceutical companies grew by 34 percent to $457 million during FY25. The export figure during FY25 is the highest-ever in Pakistan’s history. The industry recorded exports of $341 million in FY24, $328 million in FY23, and $269 million in FY22. According to a report by brokerage house Topline Securities, the growth is a result of deregulation of the pricing of non-essential drugs which has helped companies to invest more in new products and exports markets. The brokerage house expects the exports to grow further during the current fiscal year.